 | • レポートコード：MRC2012B0537 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、人工多能性幹細胞（iPSC）の世界市場を広く調査・分析し、今後の市場展望をまとめております。人工多能性幹細胞（iPSC）の種類別市場規模（ヒトiPSC、マウスiPSC）、用途別市場規模（学術研究、医薬品開発・発見、毒性スクリーニング、再生医療、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Fujifilm Holding Corporation (CDI)、ReproCELL、Astellas Pharma Inc、Ncardia、Cell Inspire Biotechnology、Sumitomo Dainippon Pharma、Pluricell Biotech、Fate Therapeutics, Inc、 ・地域別グローバル市場分析 2015年-2020年 ・人工多能性幹細胞（iPSC）の北米市場（アメリカ、カナダ、メキシコ） ・人工多能性幹細胞（iPSC）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・人工多能性幹細胞（iPSC）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・人工多能性幹細胞（iPSC）の南米市場（ブラジル、アルゼンチン） ・人工多能性幹細胞（iPSC）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ヒトiPSC、マウスiPSC ・用途別分析：学術研究、医薬品開発・発見、毒性スクリーニング、再生医療、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Induced Pluripotent Stem Cells (iPSCs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Induced Pluripotent Stem Cells (iPSCs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.7%% in the forecast period of 2020 to 2025 and will expected to reach USD 129.1 million by 2025, from USD 83 million in 2019.
Market segmentation
Induced Pluripotent Stem Cells (iPSCs) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Induced Pluripotent Stem Cells (iPSCs) market has been segmented into:
Human iPSCs
Mouse iPSCs
By Application, Induced Pluripotent Stem Cells (iPSCs) has been segmented into:
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Induced Pluripotent Stem Cells (iPSCs) market presented in the report. This section sheds light on the sales growth of different regional and country-level Induced Pluripotent Stem Cells (iPSCs) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Induced Pluripotent Stem Cells (iPSCs) market.
The report offers in-depth assessment of the growth and other aspects of the Induced Pluripotent Stem Cells (iPSCs) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Induced Pluripotent Stem Cells (iPSCs) Market Share Analysis
Induced Pluripotent Stem Cells (iPSCs) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Induced Pluripotent Stem Cells (iPSCs) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Induced Pluripotent Stem Cells (iPSCs) sales, revenue and market share for each player covered in this report.
The major players covered in Induced Pluripotent Stem Cells (iPSCs) are:
Fujifilm Holding Corporation (CDI)
ReproCELL
Astellas Pharma Inc
Ncardia
Cell Inspire Biotechnology
Sumitomo Dainippon Pharma
Pluricell Biotech
Fate Therapeutics, Inc
Among other players domestic and global, Induced Pluripotent Stem Cells (iPSCs) market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Induced Pluripotent Stem Cells (iPSCs) Market Overview
1.1 Product Overview and Scope of Induced Pluripotent Stem Cells (iPSCs)
1.2 Classification of Induced Pluripotent Stem Cells (iPSCs) by Type
1.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type in 2019
1.2.3 Human iPSCs
1.2.4 Mouse iPSCs
1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market by Application
1.3.1 Overview: Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Academic Research
1.3.3 Drug Development and Discovery
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.3.6 Others
1.4 Global Induced Pluripotent Stem Cells (iPSCs) Market by Regions
1.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Induced Pluripotent Stem Cells (iPSCs) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Fujifilm Holding Corporation (CDI)
2.1.1 Fujifilm Holding Corporation (CDI) Details
2.1.2 Fujifilm Holding Corporation (CDI) Major Business
2.1.3 Fujifilm Holding Corporation (CDI) SWOT Analysis
2.1.4 Fujifilm Holding Corporation (CDI) Product and Services
2.1.5 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.2 ReproCELL
2.2.1 ReproCELL Details
2.2.2 ReproCELL Major Business
2.2.3 ReproCELL SWOT Analysis
2.2.4 ReproCELL Product and Services
2.2.5 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astellas Pharma Inc
2.3.1 Astellas Pharma Inc Details
2.3.2 Astellas Pharma Inc Major Business
2.3.3 Astellas Pharma Inc SWOT Analysis
2.3.4 Astellas Pharma Inc Product and Services
2.3.5 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Ncardia
2.4.1 Ncardia Details
2.4.2 Ncardia Major Business
2.4.3 Ncardia SWOT Analysis
2.4.4 Ncardia Product and Services
2.4.5 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cell Inspire Biotechnology
2.5.1 Cell Inspire Biotechnology Details
2.5.2 Cell Inspire Biotechnology Major Business
2.5.3 Cell Inspire Biotechnology SWOT Analysis
2.5.4 Cell Inspire Biotechnology Product and Services
2.5.5 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sumitomo Dainippon Pharma
2.6.1 Sumitomo Dainippon Pharma Details
2.6.2 Sumitomo Dainippon Pharma Major Business
2.6.3 Sumitomo Dainippon Pharma Product and Services
2.6.4 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pluricell Biotech
2.7.1 Pluricell Biotech Details
2.7.2 Pluricell Biotech Major Business
2.7.3 Pluricell Biotech Product and Services
2.7.4 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Fate Therapeutics, Inc
2.8.1 Fate Therapeutics, Inc Details
2.8.2 Fate Therapeutics, Inc Major Business
2.8.3 Fate Therapeutics, Inc Product and Services
2.8.4 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Induced Pluripotent Stem Cells (iPSCs) Players Market Share
3.2.2 Top 10 Induced Pluripotent Stem Cells (iPSCs) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Regions
4.2 North America Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
4.3 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
4.5 South America Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
5 North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries
5.1 North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2015-2020)
5.2 USA Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
5.3 Canada Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
5.4 Mexico Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
6 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries
6.1 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2015-2020)
6.2 Germany Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
6.3 UK Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
6.4 France Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
6.5 Russia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
6.6 Italy Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries
7.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2015-2020)
7.2 China Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
7.3 Japan Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
7.4 Korea Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
7.5 India Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
8 South America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries
8.1 South America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2015-2020)
8.2 Brazil Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
8.3 Argentina Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Induced Pluripotent Stem Cells (iPSCs) by Countries
9.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
9.3 UAE Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
9.4 Egypt Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
9.5 South Africa Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Type (2015-2020)
10.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Type (2019-2024)
10.3 Human iPSCs Revenue Growth Rate (2015-2025)
10.4 Mouse iPSCs Revenue Growth Rate (2015-2025)
11 Global Induced Pluripotent Stem Cells (iPSCs) Market Segment by Application
11.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2015-2020)
11.2 Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Application (2019-2024)
11.3 Academic Research Revenue Growth (2015-2020)
11.4 Drug Development and Discovery Revenue Growth (2015-2020)
11.5 Toxicity Screening Revenue Growth (2015-2020)
11.6 Regenerative Medicine Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast (2021-2025)
12.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast (2021-2025)
12.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Regions (2021-2025)
12.3 North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)
12.4 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)
12.6 South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Induced Pluripotent Stem Cells (iPSCs) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Fujifilm Holding Corporation (CDI) Corporate Information, Location and Competitors
Table 7. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Major Business
Table 8. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)
Table 9. Fujifilm Holding Corporation (CDI) SWOT Analysis
Table 10. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 11. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. ReproCELL Corporate Information, Location and Competitors
Table 13. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Major Business
Table 14. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2018-2019)
Table 15. ReproCELL SWOT Analysis
Table 16. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 17. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Astellas Pharma Inc Corporate Information, Location and Competitors
Table 19. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Major Business
Table 20. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)
Table 21. Astellas Pharma Inc SWOT Analysis
Table 22. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 23. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Ncardia Corporate Information, Location and Competitors
Table 25. Ncardia Induced Pluripotent Stem Cells (iPSCs) Major Business
Table 26. Ncardia Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)
Table 27. Ncardia SWOT Analysis
Table 28. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 29. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Cell Inspire Biotechnology Corporate Information, Location and Competitors
Table 31. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Major Business
Table 32. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)
Table 33. Cell Inspire Biotechnology SWOT Analysis
Table 34. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 35. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Sumitomo Dainippon Pharma Corporate Information, Location and Competitors
Table 37. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Major Business
Table 38. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)
Table 39. Sumitomo Dainippon Pharma SWOT Analysis
Table 40. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 41. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Pluricell Biotech Corporate Information, Location and Competitors
Table 43. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Major Business
Table 44. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)
Table 45. Pluricell Biotech SWOT Analysis
Table 46. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 47. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Fate Therapeutics, Inc Corporate Information, Location and Competitors
Table 49. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Major Business
Table 50. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)
Table 51. Fate Therapeutics, Inc SWOT Analysis
Table 52. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 53. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Players (2015-2020)
Table 55. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Players (2015-2020)
Table 56. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Regions (2015-2020)
Table 57. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Regions (2015-2020)
Table 58. North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2015-2020)
Table 59. North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)
Table 60. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Countries (2015-2020)
Table 61. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Countries (2015-2020)
Table 62. South America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2015-2020)
Table 63. South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)
Table 64. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Countries (2015-2020)
Table 65. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)
Table 66. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Type (2015-2020)
Table 67. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Type (2015-2020)
Table 68. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Type (2021-2025)
Table 69. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2015-2020)
Table 70. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Application (2015-2020)
Table 71. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Application (2021-2025)
Table 72. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Induced Pluripotent Stem Cells (iPSCs) Picture
Figure 2. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type in 2019
Figure 3. Human iPSCs Picture
Figure 4. Mouse iPSCs Picture
Figure 5. Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application in 2019
Figure 6. Academic Research Picture
Figure 7. Drug Development and Discovery Picture
Figure 8. Toxicity Screening Picture
Figure 9. Regenerative Medicine Picture
Figure 10. Others Picture
Figure 11. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share in 2019
Figure 20. Global Top 10 Players Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Regions (2015-2020)
Figure 24. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Regions in 2018
Figure 25. North America Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 26. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 28. South America Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 30. North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)
Figure 31. North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries in 2019
Figure 32. USA Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 33. Canada Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 35. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries in 2019
Figure 37. Germany Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 38. UK Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 39. France Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 40. Russia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 41. Italy Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries in 2019
Figure 44. China Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 45. Japan Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 46. Korea Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 47. India Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 49. South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)
Figure 50. South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries in 2019
Figure 51. Brazil Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 56. UAE Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2020)
Figure 59. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Type (2015-2020)
Figure 60. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Type in 2019
Figure 61. Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Type (2021-2025)
Figure 62. Global Human iPSCs Revenue Growth Rate (2015-2020)
Figure 63. Global Mouse iPSCs Revenue Growth Rate (2015-2020)
Figure 64. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Application (2015-2020)
Figure 65. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Application in 2019
Figure 66. Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Application (2021-2025)
Figure 67. Global Academic Research Revenue Growth Rate (2015-2020)
Figure 68. Global Drug Development and Discovery Revenue Growth Rate (2015-2020)
Figure 69. Global Toxicity Screening Revenue Growth Rate (2015-2020)
Figure 70. Global Regenerative Medicine Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)
Figure 76. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)
Figure 78. South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
ヒト間葉系幹細胞（hMSC）の世界市場（～2026年） Human mesenchymal stem cells (hMSC) are multipotent stromal cells that can differentiate into a variety of cell types. Market Analysis and Insights: Global Human Mesenchymal Stem Cells (hMSC) Market The global Human Mesenchymal Stem Cells (hMSC) market size is projected to reach US$ XX million by 20…- 循環腫瘍細胞（CTC）＆がん幹細胞の世界市場（～2026年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
- 臍帯血幹細胞の世界市場（～2026年） Market Analysis and Insights: Global Cord Blood Stem Cells Market The global Cord Blood Stem Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cord Blood Stem Cells Scope and Market Size Cord Blood Stem Cells marke…
- 犬幹細胞治療の世界市場（～2026年） The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…
- 幹細胞製造の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Stem Cell Manufacturing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Stem Cell Manufacturi…